{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO-21019 Carbapenamase 1.1.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "POLICY FOR CARBAPENEMASE- PRODUCING ORGANISM (CPO)"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEPO-21019"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.1"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All staff"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "06 April 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "05 April 2024"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "DH (2010) The Health and Social Care Act 2008: code of practice for health and adult social care on the prevention and control of infections and related guidance"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Harm Free Care"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Emma Dowling Head of Nursing Infection Prevention and Control MSE"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Southend IPCC Broomfield IPCC Basildon IPCC"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Dawn Patience Director of Harm Free Care"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "06 April 2021"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group)"
                    },
                    {
                        "text": "May 21"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet \u2610 Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEPO-21019 Carbapenamase 1.1.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 9,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With: this must include Pharmacy if the document has any reference to medication"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Judith Holdsworth"
                    },
                    {
                        "text": "Lead ICN Broomfield"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": "Titi Odewumi"
                    },
                    {
                        "text": "Lead Antimicrobial Pharmacist MSE"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": "Dr Awad-El -Kariem"
                    },
                    {
                        "text": "Consultant Microbiologist /DIPC Basildon"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": "Edith Mahachi"
                    },
                    {
                        "text": "Lead ICN Basildon"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": "Dr Javeed Ahmed"
                    },
                    {
                        "text": "Consultant Virologist Southend Site"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Southend IPCC"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Broomfield IPCC"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Basildon IPCC"
                    },
                    {
                        "text": "05 March 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Decontamination Policy Isolation Policy MSEPO-20215 Hand Hygiene Policy Standard Precautions Linen Handling Policy"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 4,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/ Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Emma Dowling"
                    },
                    {
                        "text": "New MSE Policy. Replaces: 14017 Carbapenemase Producing Enterobacteriaceae IC034 Policies for Carbapenemase- Producing Organism (CPO) CPPO00138 Carbapenemase Producing Enterobacteriaceae"
                    },
                    {
                        "text": "06 April 2021"
                    },
                    {
                        "text": "1.1"
                    },
                    {
                        "text": "Judy Holdsworth"
                    },
                    {
                        "text": "Clarification to section 5, points 5.2 and 5.3"
                    },
                    {
                        "text": "09 April 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 7
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction .................................................................................................................. 4"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions .................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Role & Responsibilities within the Trust ....................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Screening ..................................................................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Screening process for CPO.......................................................................................... 7"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Transmission ................................................................................................................ 8"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Treatment ..................................................................................................................... 8"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Infection Prevention Precautions.................................................................................. 8  Environmental Cleaning ............................................................................................. 10  Training Requirements ............................................................................................... 10  Monitoring and Audit .................................................................................................. 11  Approval and Implementation..................................................................................... 11  Equality Impact Assessment ...................................................................................... 11  References ................................................................................................................. 11 Appendix 1: Preliminary Equality Analysis ........................................................................ 13"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "CPO  -  carbapenemase  producing  organisms.  Predominately  the  group  of organisms  identified  with  carbapenem  resistance  is  Enterobacteriaceae. Enterobacteriaceae are a large family of bacteria that usually live harmlessly in the gut of humans and animals. They are often associated with the most common causes of urinary tract infections, intra-abdominal and blood stream infections. They include species such as Escherichia coli, Klebsiella spp. and Enterobacter spp."
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "Carbapenems  are  an important  group  of antibiotics  normally reserved  for serious  infections  caused  by  resistant  gram  negative  bacteria  (including enterobacteriaceae).  They include  the antibiotics:  meropenem,  ertapenem, imipenem and doripenem."
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "Carbapenamases are enzymes produced by a small, but growing number of bacteria which are able to destroy carbapenem antibiotics. The emergence of CPO  is  a  major  public  health  concern,  with  a  rapid  increase  in  cases worldwide.  Although  still  relatively  rare  in  the  United  Kingdom,  these organisms are endemic in other areas of the world and there is a risk of introduction to the UK, and subsequent person-to-person spread in health care settings."
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.4,
                "text": "There are very limited options available to treat infections caused by CPO. In addition  to  this,  there  are  few  new  antibiotics  in  development  to  provide therapeutic cover for the next 10-20 years. Human infections with CPO are associated with poorer patient outcomes, increased morbidity, mortality and higher hospital costs"
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "This policy outlines the process for the management and control of infection of patients with carbapenemase producing organisms (CPO) within the MSE."
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "type": "table",
            "sequence_num": 25,
            "data": {
                "num_rows": 5,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "A hospital transmissible infection"
                    },
                    {
                        "text": "Is defined as one that can be communicated to staff and patients within hospital"
                    },
                    {
                        "text": "AHP"
                    },
                    {
                        "text": "Allied Health Professionals"
                    },
                    {
                        "text": "Alert organisms and conditions"
                    },
                    {
                        "text": "Are those identified as posing a public health risk to patients, staff or visitors as defined by the Department of Health (DOH 2007)"
                    },
                    {
                        "text": "Antibiotic resistance"
                    },
                    {
                        "text": "The ability of bacteria and other microorganisms to resist the"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 26,
            "data": {
                "num_rows": 20,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "effects of an antibiotic to which they were once sensitive"
                    },
                    {
                        "text": "Carbapenems"
                    },
                    {
                        "text": "A group of broad spectrum antibiotics, including Meropenem Impenem and Ertapenem"
                    },
                    {
                        "text": "Carbapenemase"
                    },
                    {
                        "text": "Enzymes (such as Klebsiella pneumoniae Carbapenemase (KPC), OXA-48 Carbapenemase, New Delhi Metalo-beta Carbapenemase and Verona integron-encoded metallo-\u03b2- lactamase (VIM)) produced by some bacteria which cause destruction of the Carbapenem antibiotics, e.g. Meropenem, thus resulting in resistance."
                    },
                    {
                        "text": "Colonisation"
                    },
                    {
                        "text": "Is the presence, growth and multiplication of an organism without observable clinical symptoms or immune reaction on the patient"
                    },
                    {
                        "text": "Commensal"
                    },
                    {
                        "text": "Is a bacterium that constitutes to the normal flora of the healthy body"
                    },
                    {
                        "text": "Contact"
                    },
                    {
                        "text": "Can be a household contact, sexual partner or shared space contacts (i.e. same room or hospital bay)"
                    },
                    {
                        "text": "CRO"
                    },
                    {
                        "text": "Carbapenem- Resistant Organisms"
                    },
                    {
                        "text": "CPE"
                    },
                    {
                        "text": "Carbapenemase Producing Enterobacteriaceae"
                    },
                    {
                        "text": "CPO"
                    },
                    {
                        "text": "Carbapenemase Producing Organism"
                    },
                    {
                        "text": "CRT"
                    },
                    {
                        "text": "Cleaning Response Team"
                    },
                    {
                        "text": "DIPC"
                    },
                    {
                        "text": "Director for Infection Prevention and Control"
                    },
                    {
                        "text": "Enterobacteriaceae"
                    },
                    {
                        "text": "Are a group of gram negative bacteria commonly found as commensals in the human gastrointestinal tract"
                    },
                    {
                        "text": "Gram-negative bacteria"
                    },
                    {
                        "text": "Gram-negative bacteria include many of the bacteria normally found in the gastrointestinal tract."
                    },
                    {
                        "text": "IPCC"
                    },
                    {
                        "text": "Infection Prevention and Control Committee"
                    },
                    {
                        "text": "IPCT"
                    },
                    {
                        "text": "Infection Prevention and Control Team"
                    },
                    {
                        "text": "MSE"
                    },
                    {
                        "text": "Mid and South East Essex Trust"
                    },
                    {
                        "text": "PEG"
                    },
                    {
                        "text": "Percutaneous Endoscopic Gastrostomy"
                    },
                    {
                        "text": "Rectal swab"
                    },
                    {
                        "text": "A rectal was is a specimen taken by gently inserting a swab inside the rectum 3-4 cms beyond the anal sphincter, rotating gently and removing. Normal saline can be used to moisten the swab prior to insertion. The swab should have visible faecal material to enable organism detection in the laboratory. A rectal swab should not be mistaken for a perineal swab."
                    },
                    {
                        "text": "Source isolation"
                    },
                    {
                        "text": "Is the physical separation of one patient from another, in order to prevent spread of infection"
                    },
                    {
                        "text": "Spp."
                    },
                    {
                        "text": "Species"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role & Responsibilities within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Infection Prevention and Control Site Committee (IPCC) is responsible for the review of this policy at least every three years, but more frequently if there are changes to Infection Prevention and Control Legislation or guidance."
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "The Chief Executive has overall responsibility for ensuring that the Trust has the  necessary  management  systems  in  place  to  enable  the  effective implementation  of this  policy  and  overall  responsibility  for  the  health  and safety of staff, patients and visitors"
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.3,
                "text": "The  Site  Director  of  Infection  Prevention  and  Control  (DIPC)  is responsible for ensuring that there are effective and appropriate arrangements for the prevention and control of infection throughout the Trust."
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.4,
                "text": "Head of Infection Prevention and Control MSE - will give advice against this policy and ensure that all staff have access to this policy via the Trust Intranet, and ensure that it is updated every three years or in line with current national guidance."
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.5,
                "text": "The Infection Prevention and Control Teams (IPCT) are responsible for ensuring all staff are made aware of this policy and advising ward staff on control measures, providing them with the necessary advice"
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.6,
                "text": "All Staff must comply with this policy and act in a responsible manner, liaising with the IPCT in a timely manner if in need of advice or support. All staff have a responsibility to ensure that Infection Prevention and Control is embedded into their everyday practice and applied consistently at all times"
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Screening"
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Any patient who has received hospital care outside the United Kingdom is at risk  of  carrying  CPO,  therefore  strict  active  screening  of  any  patient transferred across borders into a healthcare facility in the United Kingdom is advised"
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Countries  with  reported  high  prevalence  of  healthcare-associated carbapenemase- producing organisms are:"
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "type": "table",
            "sequence_num": 37,
            "data": {
                "num_rows": 12,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Bangladesh"
                    },
                    {
                        "text": "North Africa (all)"
                    },
                    {
                        "text": "The Balkans"
                    },
                    {
                        "text": "Malta"
                    },
                    {
                        "text": "China"
                    },
                    {
                        "text": "Middle East (all)"
                    },
                    {
                        "text": "Cyprus"
                    },
                    {
                        "text": "Pakistan"
                    },
                    {
                        "text": "Greece"
                    },
                    {
                        "text": "South East Asia"
                    },
                    {
                        "text": "India"
                    },
                    {
                        "text": "South / Central America"
                    },
                    {
                        "text": "Ireland"
                    },
                    {
                        "text": "Turkey"
                    },
                    {
                        "text": "Israel"
                    },
                    {
                        "text": "Taiwan"
                    },
                    {
                        "text": "Italy"
                    },
                    {
                        "text": "USA"
                    },
                    {
                        "text": "Japan"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "This is not an exhaustive list: admission to any hospital abroad should be"
                    },
                    {
                        "text": "considered when making a risk assessment."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "UK  regions/areas  with  reported  high  prevalence  of  healthcare-associated carbapenemase- producing organisms are:"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "type": "table",
            "sequence_num": 39,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "The North West (especially Manchester/Cheshire/Leicester)"
                    },
                    {
                        "text": "London"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "A patient should be screened for CPO on admission if one or more of the following applies:"
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "type": "table",
            "sequence_num": 41,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "\uf0b7"
                    },
                    {
                        "text": "Any patient who has been an inpatient in a hospital abroad within the last"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "12 months including renal haemodialysis ( both elective \u2018holiday dialysis \u2018"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "and emergency dialysis)"
                    },
                    {
                        "text": "\uf0b7"
                    },
                    {
                        "text": "Is a direct transfer from a UK region/area with reported high prevalence"
                    },
                    {
                        "text": "\uf0b7"
                    },
                    {
                        "text": "Previously been colonised or had an infection with a CPO"
                    },
                    {
                        "text": "\uf0b7"
                    },
                    {
                        "text": "Any patients previously colonised or infected with a CPO or, are known to"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "have had contact with a colonised / infected person"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.5,
                "text": "Further swabs for screening of other organisms  will also be required i.e. MRSA and MDRA in line with Trust policy. This needs to be done in addition to the screening of CPO."
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Screening process for CPO"
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "type": "table",
            "sequence_num": 44,
            "data": {
                "num_rows": 19,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "\uf0b7"
                    },
                    {
                        "text": "Informed consent must be gained from the patient wherever possible. If a patient"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "declines the screen, document this in the patients' medical notes and consider taking a"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "stool specimen. Document on the pathology form why a stool sample has to be sent"
                    },
                    {
                        "text": "\uf0b7"
                    },
                    {
                        "text": "CPO information must be given to the patient or relatives"
                    },
                    {
                        "text": "\uf0b7"
                    },
                    {
                        "text": "Gloves and aprons must be worn when obtaining the CPO screen"
                    },
                    {
                        "text": "\uf0b7"
                    },
                    {
                        "text": "A rectal swab must be obtained using a dry swab. The cotton tip of the swab"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "should be inserted just inside the rectum gently and rotated to come into"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "contact with faeces"
                    },
                    {
                        "text": "\uf0b7"
                    },
                    {
                        "text": "Additional swabs must be taken from any wounds (surgical wounds, ulcers,"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "lesions) or device related sites (cannula, tracheostomy, PEG, drains or lines)"
                    },
                    {
                        "text": "\uf0b7"
                    },
                    {
                        "text": "Send swabs to the laboratory labelled for CPO testing \u2013 include any relevant"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "clinical details"
                    },
                    {
                        "text": "\uf0b7"
                    },
                    {
                        "text": "A stool sample will be accepted if a rectal swab is deemed inappropriate e.g.,"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "patients with a stoma, paediatrics. Please label the stool sample for CPO"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "testing and provide details of why a stool sample has been sent instead of a"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "rectal swab"
                    },
                    {
                        "text": "\uf0b7"
                    },
                    {
                        "text": "Screens must be taken on day 0 e.g. day of admission, day 2 (48 hours after"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "the 1st screen) and day 4 (48 hours after the 2nd screen). If any of the screens"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "return CPO positive, cease screening"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "If the first result is negative, two further negative samples will be required and a risk assessment undertaken before removing the patient from isolation. The"
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 0,
                "text": "screens should be taken 48 hours apart (i.e. if the initial sample was taken on day 0 the other two samples should be taken on days 2 and 4)"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "A newly diagnosed CPO patient will have an Alert added to Medway/Lorenzo system by the IPCT."
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.3,
                "text": "If a patient found to be positive for CPO and has spent time in an open ward or bay before the positive result was known, the other patients on that ward will require screening. The IPCT will provide guidance on contact tracing and screening"
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.4,
                "text": "In the event of an outbreak of CPO (two or more cases linked in time and place) the Trust outbreak policy will be followed."
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Transmission"
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "CPO can spread person to person by faecal contamination of the hands, transferred from an environmental source or contaminated equipment."
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Treatment"
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Antibiotic treatment options are limited and determined by sensitivity testing results. Any treatment, including surgical prophylaxis, should be discussed with a Consultant Microbiologist"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Infection Prevention Precautions"
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "Patients who meet the at-risk criteria or who are found to be positive for CPO must be isolated in a single room with en-suite facilities and with the door closed at all times and Source Isolation sign displayed"
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "A patient who is found to be positive for CPO should remain in isolation for the duration of their stay in hospital even if they subsequently test negative, as the patient may continue to be positive at an undetected level"
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.3,
                "text": "Note  that  the  most  important  means  of  CPO  spread is  via  contaminated hands. A high standard of hand hygiene must be maintained at all times before and in between each patient contact. Encourage the patient to clean their hands before meals and after using the toilet/commode."
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.4,
                "text": "Single use disposable long sleeved aprons and gloves should be used"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.5,
                "text": "Visitors are not required to wear protective clothing unless involved in the patient's personal care, when an apron should be worn. Visitors taking part in care activities must be provided with PPE, shown how to apply and remove it and  the  correct  waste  streams  to  dispose  of  PPE  into.  Visitors  must  be advised to wash their hands immediately prior to leaving the isolation room"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 0,
                "text": "and must not wander around the ward or visit other patients. Visitors who are undertaking multiple hospital visits must be advised to visit the affected patient last."
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.6,
                "text": "Patients with confirmed or suspected CPO should ideally have designated staff to care for them, but it is accepted that this may not be practicable and strict adherence to source isolation precautions must be maintained. Staff such as Allied Health Professionals (AHP) should, where practical, see all other patients prior to those with confirmed or suspected CPO and adherence to source isolation precautions must be maintained. There must be precautions identified for support staff e.g. catering and cleaning staff"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.7,
                "text": "Equipment must be kept to an absolute minimum and designated for the sole use of the patient in isolation. This includes blood pressure monitoring equipment, tympanic thermometer, dressing trolley and commode. Equipment may only be used on other patients after it has received thorough decontamination"
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 1,
                "text": "\uf0b7  Linen must be changed daily and disposed of in a red alginate bag and then into a white linen bag. Used linen must be disposed of promptly .Linen bags must not be placed on the floor of the isolation room- this reduces the potential risk of environmental contamination"
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.8,
                "text": "Environmental cleaning and decontamination, with an enhanced focus on frequently touched areas must be carried out"
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.9,
                "text": "Clinical waste must be placed in an orange waste bag"
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "Patients can use crockery and cutlery from the main kitchen, no special precautions are required"
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.11,
                "text": "If a patient has had 3 negative results for CPO following testing (and the only indication for isolation was transfer/admission/contact tracing screening) isolation can be discontinued and the patient can be nursed in a main bay. No further screening is required"
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.12,
                "text": "The transfer of patients to other departments must be avoided where possible. It is preferable for investigations to be undertaken on the ward i.e. x-ray"
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.13,
                "text": "If the patient requires a planned visit to other departments this must be done with the full involvement of the IPCT, who will advise on the precautions that must be taken"
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.14,
                "text": "Areas such as theatres will have more detailed plans on how to accommodate patients with confirmed/ suspected CPO, including decontamination with hydrogen peroxide"
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.15,
                "text": "If a patient needs to be transferred urgently due to clinical reasons (i.e. critical care), the receiving area should be fully aware of the patient's' diagnosis and required precautions"
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.16,
                "text": "Renal haemodialysis patients: any patient who has who has had away from base dialysis (holiday dialysis) abroad at a listed hot country must be dialysed in a single room until they have had one negative screen."
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.17,
                "text": "If a confirmed or suspected CPO patient is transferred without the full knowledge of the receiving ward this is a Serious Incident and a Datix report must be completed in accordance with the Trust's Incident Reporting Policy. The IPCT must additionally be informed, to assess the need for further screening of potential contacts"
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Environmental Cleaning"
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "Domestic Services must be made aware that the patient is receiving special precautions so that they can provide any necessary additional cleaning equipment"
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "Yellow colour-coded cleaning equipment must be available and the room. The room will be cleaned daily by The Cleaning Response Team(CRT)"
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "The room must be cleaned daily with a sporicidal agent e.g. Tristel or DIFF-X solution"
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.4,
                "text": "Following discharge the room should have all linen and curtains removed. The room should have an initial clean with detergent and hot water. Following this the room must have hydrogen peroxide decontamination"
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.5,
                "text": "Pillows must be disposed of. The mattress must be checked as safe to re-use"
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.6,
                "text": "All disposable equipment to be disposed of including, unused dressings, ointments, tapes, wipes, gloves etc."
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.7,
                "text": "Staff must ensure that all equipment that has been in contact with the patient remains in the room and is cleaned as part of the hydrogen peroxide decontamination"
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Training Requirements"
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "All Trust staff to undertake Mandatory Infection Prevention and Control updates and Donning and Doffing updates. The IPCT has primary responsibility for providing training on the policy where needed. Managers have the responsibly to support the IPCT by ensuring that staff are able to attend training sessions in response to identified needs"
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Monitoring and Audit"
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "Outlined below is the Trust's process of monitoring compliance with, and the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "type": "table",
            "sequence_num": 86,
            "data": {
                "num_rows": 2,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings / monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Knowledge / compliance/ practice"
                    },
                    {
                        "text": "Audit"
                    },
                    {
                        "text": "Infection Prevention and Control Team"
                    },
                    {
                        "text": "On a case by case basis"
                    },
                    {
                        "text": "IPCC"
                    },
                    {
                        "text": "IPPC"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Approval and Implementation"
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "All policies, procedures and guidelines will be approved by the MSE IPCC's, which  are  the  specialist  groups  with  the  authority  to  approve  MSE  IPC Polices.  These  will  then  be  forwarded  to  the  Document  control  team  for submission and ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "It is the author's responsibility to inform the Director of Harm Free Care of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Equality Impact Assessment"
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Refer to appendix 1)"
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Damani N (2012) - Manual of Infection Prevention and Control, 3rd Edition. Oxford: Oxford University Press"
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Chief Medical Officer (2011) - Annual Report of the Chief Medical Officer Infections and the rise of antimicrobial resistance Vol 2. DH: London. Available at: http://media.dh.gov.uk/network/357/files/2013/03/CMO-Annual-Report- Volume-2-20111.pdf Last accessed 16.09.2018"
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Public Health England (2013) - Acute Trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteria. Available at:"
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 0,
                "text": "https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/ 329227/Acute_trust_toolkit_for_the_early_detection.pdf . Last accessed 16.09.018"
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Public Health England (2015) - Toolkit for managing carbapenemase- producing Enterobacteria in none acute and community settings. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/ 439801/CPE-Non-AcuteToolkit_CORE.pdf"
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Policy for Carbapenemase-Producing Organism (CPO) / MSEPO-21019 /1.1"
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Policy for Carbapenemase-Producing Organism (CPO) / MSEPO-21019 /1.1"
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Preliminary Equality Analysis"
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to Policy for Carbapenemase-Producing Organism (CPO) / MSEPO-21019: (please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "type": "table",
            "sequence_num": 104,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 105,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Standardisation of three site policies"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "To have a single MSE Policy"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Staff and patients"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 & 2."
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 106,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Emma Dowling"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Head of Nursing Infection Prevention and Control MSE"
                    },
                    {
                        "text": "23 March 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "If you have identified any negative impact in the preliminary analysis above, please request and complete the full Equality Impact Assessment (EIA) from Document Control."
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 108
        }
    ]
}